umifenovir has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dong, Z; Jiang, Y; Kim, MO; Laster, KV; Li, X; Liu, K; Lu, X; Wang, D; Wei, Y; Yang, N; Yu, Y; Yuan, B; Zhao, L | 1 |
1 other study(ies) available for umifenovir and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase.
Topics: Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Indoles; Protein Kinases; Sulfides | 2022 |